Skip to Main Content
  • Smilow Cancer Hospital Phase I Unit
    55 Park Street
    Ste First Floor
    New Haven, CT 06511

Patricia LoRusso, DO

Medical Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine and Medical Oncology

Biography

Oncologist Patricia LoRusso, DO, associate director of innovative medicine at Yale Medicine, has expertise in testing new treatments on patient volunteers who have advanced stages of cancer. Her passion is bringing research breakthroughs into the clinic to help patients with different types and stages of cancer.

The clinical trials at Yale Cancer Center offer access to experimental drugs that are sometimes a patient’s last and best hope, says Dr. LoRusso. Therapies that prove successful can advance through the U.S. Food and Drug Administration approval process. “Many of the drugs tested here will help generations of cancer patients,” says Dr. LoRusso. In her career, 14 cancer drugs she has performed clinical trials on, which she refers to as her “children,” have gone on to gain FDA approval.

Dr. LoRusso leads the Phase I clinical trials infusion center at Smilow Cancer Hospital at Yale New Haven. She infuses the center with a warm, team-focused approach that puts patients at the center of care. “We’re improving patients’ lives in Connecticut and beyond,” says Dr. LoRusso.

Titles

  • Professor of Medicine (Medical Oncology)
  • Professor of Medicine
  • Associate Cancer Center Director, Experimental Therapeutics

Education & Training

  • Fellowship
    Wayne State University (1988)
  • Residency
    Riverside Osteopathic Hospital (1984)
  • Internship
    Riverside Osteopathic Hospital (1982)
  • DO
    Michigan State University (1981)

Additional Information

Biography

Oncologist Patricia LoRusso, DO, associate director of innovative medicine at Yale Medicine, has expertise in testing new treatments on patient volunteers who have advanced stages of cancer. Her passion is bringing research breakthroughs into the clinic to help patients with different types and stages of cancer.

The clinical trials at Yale Cancer Center offer access to experimental drugs that are sometimes a patient’s last and best hope, says Dr. LoRusso. Therapies that prove successful can advance through the U.S. Food and Drug Administration approval process. “Many of the drugs tested here will help generations of cancer patients,” says Dr. LoRusso. In her career, 14 cancer drugs she has performed clinical trials on, which she refers to as her “children,” have gone on to gain FDA approval.

Dr. LoRusso leads the Phase I clinical trials infusion center at Smilow Cancer Hospital at Yale New Haven. She infuses the center with a warm, team-focused approach that puts patients at the center of care. “We’re improving patients’ lives in Connecticut and beyond,” says Dr. LoRusso.

Titles

  • Professor of Medicine (Medical Oncology)
  • Professor of Medicine
  • Associate Cancer Center Director, Experimental Therapeutics

Education & Training

  • Fellowship
    Wayne State University (1988)
  • Residency
    Riverside Osteopathic Hospital (1984)
  • Internship
    Riverside Osteopathic Hospital (1982)
  • DO
    Michigan State University (1981)

Additional Information

  • Smilow Cancer Hospital Phase I Unit
    55 Park Street
    Ste First Floor
    New Haven, CT 06511